跳转到内容

羟基卡替洛尔

维基百科,自由的百科全书
羟基卡替洛尔
臨床資料
其他名稱8-Hydroxycarteolol
ATC碼
  • 未分配
识别信息
  • 8-Hydroxy-52-hydroxy-3-[(2-methyl-2-propanyl)amino]propoxy3,4-dihydro-2(1H)-quinolinone
CAS号59826-22-1
PubChem CID
ChemSpider
ChEBI
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
化学信息
化学式C16H24N2O4
摩尔质量308.38 g·mol−1
3D模型(JSmol英语JSmol
  • O=C2Nc1c(O)ccc(OCC(O)CNC(C)(C)C)c1CC2
  • InChI=1S/C16H24N2O4/c1-16(2,3)17-8-10(19)9-22-13-6-5-12(20)15-11(13)4-7-14(21)18-15/h5-6,10,17,19-20H,4,7-9H2,1-3H3,(H,18,21)
  • Key:TVZJLAKRXHGVOK-UHFFFAOYSA-N

羟基卡替洛尔(英語:Hydroxycarteolol,也称为8-羟基卡替洛尔8-Hydroxycarteolol)是一种含氮有机化合物,化学式C
16
H
24
N
2
O
4
,能作为β受体阻滞剂,也是卡替洛尔在体内的主要代谢产物[1][2]

参考文献

[编辑]
  1. ^ Igarashi H, Katsuta Y, Sawa K, Nakazato Y, Kawasaki T. A comparison of the opacifying effects of carteolol.HCl and 8-hydroxycarteolol.HCl in the isolated porcine cornea. Fundam Appl Toxicol. Apr 1990, 14 (3): 554–559. PMID 2340982. doi:10.1093/toxsci/14.3.554. 
  2. ^ Jasper JR, Michel MC, Insel PA. The beta-adrenoceptor antagonist carteolol and its metabolite 8-hydroxycarteolol have different intrinsic sympathomimetic activities. Br J Clin Pharmacol. 1990, 30 (Suppl 1): 109S–111S. PMC 1368107可免费查阅. PMID 2176514. doi:10.1111/j.1365-2125.1990.tb05477.x.